Future Tech Jobs
Future Tech Jobs
This role involves providing medical leadership within GSK's oncology clinical development team, focusing on genitourinary (GU) cancers. The Medical Director will lead medical monitoring, ensure patient safety, interpret clinical data, and contribute to study design and regulatory submissions. Working closely with cross-functional teams, the role integrates physician-level insight into clinical strategy and drug development execution.
Lead clinical development for hepatology assets, designing and executing translational and clinical studies to advance novel liver disease treatments. Provide medical oversight, shape development strategies, and collaborate across functions to deliver innovative medicines. Engage with regulators and external experts to drive proof-of-concept and lifecycle expansion opportunities.
Leads clinical development strategy for oncology assets, defining scientific narrative, benefit-risk frameworks, and decision pathways across the lifecycle. Acts as clinical authority within cross-functional teams and external engagements, leveraging advanced analytics and AI to accelerate drug development. Focuses on integrating clinical, regulatory, and commercial strategies to deliver impactful cancer therapies.
Leads cross-programme scientific strategy and integration across GSK’s oncology portfolio, with a focus on hematology. Provides expert guidance on disease biology, biomarker strategies, and clinical development innovation across multiple assets. Champions data-driven decision-making, trial innovation, and external engagement to align portfolio direction and accelerate development.
Lead scientific input into oncology clinical trial design, data interpretation, and regulatory documentation within a global pharmaceutical environment. Contribute to study-level execution and strategic insights while collaborating across multidisciplinary teams. Focus on advancing cancer therapies with high unmet need through rigorous clinical science and cross-functional partnership.
Leads clinical development for oncology assets, focusing on genitourinary (GU) cancers, with responsibility for designing and executing global Phase 1-3 trials. Works cross-functionally to generate clinical evidence, engage key external experts, and support regulatory submissions and product launches. Operates in a matrix environment across strategy, medical affairs, and regulatory teams.
This role involves leading clinical development for oncology therapeutics, specifically in genitourinary (GU) cancers, within a global matrix environment. The Senior Medical Director will design and execute Phase 1-3 clinical trials, ensure scientific integrity of study data, and engage with internal and external experts to advance GSK’s oncology portfolio. The position requires deep expertise in medical oncology, strong leadership in cross-functional teams, and active involvement in regulatory and strategic initiatives.
Lead the clinical development strategy for antibody-drug conjugates (ADCs) across multiple tumor types, from early-phase through registrational trials and market launch. Drive integrated clinical and translational research, represent the asset at key governance forums, and shape portfolio-level decision-making in oncology. Work across global cross-functional teams to advance innovative therapies within a matrixed biopharma environment.
Leads the end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch readiness. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and leading cross-functional teams in a matrixed environment. Involves governance leadership, scientific advisory boards, and integration of innovative approaches such as AI/ML and real-world evidence to accelerate development.
Leads the clinical development strategy for antibody-drug conjugates (ADCs) in oncology, spanning early- to late-phase trials across multiple tumor types. Responsible for end-to-end asset development, including regulatory approval and launch readiness, with a focus on scientific rigor, innovation in trial design, and cross-functional collaboration. Engages with global health authorities, governance bodies, and external experts to shape clinical and translational strategies.
Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and market launch. Drives integrated clinical strategy, translational research, regulatory submissions, and cross-functional collaboration across global teams. Engages with governance bodies, scientific advisory boards, and external experts to shape development and competitive positioning.
This role leads clinical strategy for oncology assets across their lifecycle, defining the scientific narrative, benefit-risk framework, and development roadmap. The Executive Medical Director acts as the clinical authority within cross-functional teams, drives governance decisions, and leverages AI and advanced analytics to accelerate data-driven development. They also represent Clinical Development in regulatory and external engagements while mentoring talent and shaping enterprise-level strategy.
Leads clinical development strategy for oncology assets, defining scientific narrative, benefit-risk frameworks, and decision-making across the asset lifecycle. Serves as the primary clinical authority, guiding governance, regulatory engagement, and cross-functional alignment while leveraging AI and advanced analytics to accelerate development. Mentors clinical talent and shapes enterprise-level standards in a dynamic R&D environment.
Leads clinical development strategy for oncology assets, defining scientific narratives and benefit-risk frameworks across the product lifecycle. Serves as the primary clinical authority, guiding governance decisions and representing Clinical Development in internal and external forums. Integrates AI-driven insights and advanced analytics to accelerate data-informed decision-making and shape innovative development pathways in cancer therapeutics.
Leads scientific and strategic integration across GSK's hematology oncology portfolio, ensuring cross-program alignment and innovation in clinical development. Provides expert guidance on disease biology, biomarker strategies, and trial design while shaping portfolio-level decision-making. Operates as a senior individual contributor interfacing with clinical teams, external experts, and regulatory bodies.
